Literature DB >> 1331500

A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus.

H Tada1, K Khalili.   

Abstract

We have identified a novel brain-derived single-stranded-DNA-binding protein that interacts with a region of the human neurotropic JC virus enhancer designated the lytic control element (LCE). This nuclear factor, LCP-1 (for lytic control element-binding protein 1), specifically recognizes the LCE, as determined by gel retardation assays. Alkylation interference showed that specific nucleotides within the LCE were contacted by LCP-1. Subsequent experiments revealed that point mutations within the LCE differentially affected LCP-1 binding. UV cross-linking and competition analysis suggested that the LCP-1 DNA-protein complexes were 50 to 52 and 100 to 120 kDa in size. Promoter mutations that affected LCP-1 binding reduced early mRNA transcription during the early phase of the lytic cycle. However, upon DNA replication in the presence of JC virus T antigen, when early mRNA initiation shifts to new locations indicative of the late phase, the LCP-1 mutations had no effect. We suggest that the JC virus early transcription unit is differentially regulated by LCP-1 prior to but not after DNA replication, suggesting a novel mechanism by which DNA structure regulates eukaryotic gene expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331500      PMCID: PMC240302     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Mechanisms for diversity in gene expression patterns.

Authors:  K Struhl
Journal:  Neuron       Date:  1991-08       Impact factor: 17.173

2.  Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen.

Authors:  P J Mitchell; C Wang; R Tjian
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

3.  Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.

Authors:  B L Padgett; D L Walker; G M ZuRhein; R J Eckroade; B H Dessel
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

4.  JC virus enhancer-promoter active in human brain cells.

Authors:  S Kenney; V Natarajan; D Strike; G Khoury; N P Salzman
Journal:  Science       Date:  1984-12-14       Impact factor: 47.728

5.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

Review 6.  New human papovaviruses.

Authors:  B L Padgett; D L Walker
Journal:  Prog Med Virol       Date:  1976

7.  An altered DNA conformation detected by S1 nuclease occurs at specific regions in active chick globin chromatin.

Authors:  A Larsen; H Weintraub
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

8.  Regulation of the host range of human papovavirus JCV.

Authors:  L Feigenbaum; K Khalili; E Major; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

9.  Extinction of JC virus tumor-antigen expression in glial cell--fibroblast hybrids.

Authors:  A H Beggs; R J Frisque; G A Scangos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  Dysmyelination in transgenic mice containing JC virus early region.

Authors:  B D Trapp; J A Small; M Pulley; G Khoury; G A Scangos
Journal:  Ann Neurol       Date:  1988-01       Impact factor: 10.422

View more
  16 in total

1.  Reciprocal interaction between two cellular proteins, Puralpha and YB-1, modulates transcriptional activity of JCVCY in glial cells.

Authors:  M Safak; G L Gallia; K Khalili
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Activating transcription from single stranded DNA.

Authors:  T Tomonaga; D Levens
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Characterization of the DNA-binding domain of the avian Y-box protein, chkYB-2, and mutational analysis of its single-strand binding motif in the Rous sarcoma virus enhancer.

Authors:  A Nambiar; S K Swamynathan; J C Kandala; R V Guntaka
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

4.  NonO enhances the association of many DNA-binding proteins to their targets.

Authors:  Y S Yang; M C Yang; P W Tucker; J D Capra
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

5.  Cloning and characterisation of a nuclear, site specific ssDNA binding protein.

Authors:  M P Smidt; B Russchen; L Snippe; J Wijnholds; G Ab
Journal:  Nucleic Acids Res       Date:  1995-07-11       Impact factor: 16.971

6.  The embryonic enhancer-binding protein SSAP contains a novel DNA-binding domain which has homology to several RNA-binding proteins.

Authors:  D J DeAngelo; J DeFalco; L Rybacki; G Childs
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

7.  The JC virus minimal core promoter is glial cell specific in vivo.

Authors:  C J Krebs; M T McAvoy; G Kumar
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

Review 8.  Puralpha: a multifunctional single-stranded DNA- and RNA-binding protein.

Authors:  G L Gallia; E M Johnson; K Khalili
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

Review 9.  Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).

Authors:  Amir Khalili; Michael Craigie; Martina Donadoni; Ilker Kudret Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

10.  Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha.

Authors:  C F Chang; G L Gallia; V Muralidharan; N N Chen; P Zoltick; E Johnson; K Khalili
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.